Catalan Network of Oncology
Descripció del projecte
The Catalan Network of Oncology treats 60% of cancer patients in Catalonia. It is made up of the Catalan Health Institute (ICS) and the Catalan Oncology Institute (ICO). On the one hand, the ICS runs two large hospitals offering cancer care: Vall d’Hebron University Hospital and the Arnau Vilanova University Hospital. The ICO, on the other, can be found in Hospitalet, centres in Girona, Badalona, Camp de Tarragona and Terres de l’Ebre.
The Network was born from the desire to become a world benchmark against cancer. A benchmark for innovation, research and care in Europe and the world. The Catalonia Health Plan 2016-2020 defines cancer as one of the region’s health priorities. It establishes strategic alliances and resource concentration to promote networks between tertiary centres of reference and hospitals in the territory.
The Catalan Network of Oncology care model works on the following lines:
- Frequent and tertiary tumour programme: encompasses all care activity related to patients already diagnosed and the conventional therapeutic process.
- Rare tumour programme: therapeutic plan applied to patients with rare tumours
- Clinical research programme: includes all treatment within a clinical trial
- Palliative care: care aimed at improving the quality of life of people with cancer
- Associated Oncology Pharmacy Unit: improvement in the management capacity of the pharmacy, both in purchasing policies and in the management of service provision
- Hospital tumour register and information systems: integration of information from different centres with the aim of facilitating a shared information unit
This model is reflected in that of other world leaders in cancer treatment. Committed to precision medicine, which allows personalised treatment and knowledge management, facilitating data recording, evaluation of results and transfer of information between professionals.
Institucions del campus involucrades
Vall d'Hebron Research Institute
Vall d'Hebron Institute of Oncology
9:00h a 20:00h
There are more than 3,000 nurses and nursing assistants at Hospital Vall d’Hebron. The work they do in the centre is vital and they are leaders both in nursing care and research. Getting to this point was a long process, as Mariona Creus, former nursing director, and Maria Àngels Barba, the current director, recall.
The Master's Degree in Biomedical and Translational Research is an official programme created to train researchers with the requisite combination of scientific knowledge and skills to contribute to the future success of biomedical research.
The winning proposal for the transformation of the Vall d’Hebron Campus is the project directed by Jordi Badia, Antoni Ubach and Miquel Espinet. The project presented by the architects includes a new research building for the Vall d'Hebron Research Institute, with an expandable area of 5,000 m2 and a budget of €15 million funded by ERDF (European Regional Development Fund).
The constant search for excellence is part of Hospital Vall d’Hebron’s nature. The biggest hospital in Catalonia and the leader in many fields, headed since February 2015 by Dr. Vicenç Martínez Ibáñez, who has a close personal and professional relationship with the Hospital. Dr. Martínez Ibáñez says that if Vall d’Hebron did not exist, it would need to be invented. The current director trained at the hospital, where he was one of the protagonists of an historic moment: the first paediatric liver transplant in Spain. Now, he is committed to continuing this legacy and, always putting the patient first, achieving excellence across all staff.